Miriam F Moffatt Selected Research

Miriam F Moffatt Research Topics

Disease

32	Asthma (Bronchial Asthma) 01/2020 - 10/2002
9	Inflammation (Inflammations) 05/2022 - 04/2005
8	Infections 05/2022 - 03/2003
8	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 12/2011
4	Lung Diseases (Lung Disease) 01/2022 - 02/2015
3	Obesity 10/2021 - 02/2015
3	Neoplasms (Cancer) 01/2021 - 02/2014
3	Atopic Dermatitis (Atopic Eczema) 01/2017 - 06/2003
3	Hypersensitivity (Allergy) 01/2017 - 05/2003
2	Human Influenza (Influenza) 03/2019 - 01/2018
1	Dysbiosis 05/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Disease Progression 01/2022
1	Virus Diseases (Viral Diseases) 05/2021
1	Mesothelioma 01/2021
1	Respiratory Syncytial Virus Infections 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019
1	Neoplasm Metastasis (Metastasis) 11/2019
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Immune System Diseases (Immune Disorders) 01/2017
1	Cystic Fibrosis (Mucoviscidosis) 01/2017
1	Bronchiectasis 01/2017
1	Rhinitis 01/2016
1	Cough 10/2015
1	Seasonal Allergic Rhinitis (Hay Fever) 04/2015
1	Sepsis (Septicemia) 01/2015
1	Kidney Diseases (Kidney Disease) 02/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2014
1	Basal Cell Carcinoma (Rodent Ulcer) 04/2012
1	Thyroid Diseases (Thyroid Disease) 04/2012
1	Carcinogenesis 04/2012

Drug/Important Bio-Agent (IBA)

14	Immunoglobulin E (IgE)IBA 08/2017 - 10/2002
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2007
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2012
4	Biological ProductsIBA 10/2021 - 02/2010
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2012
3	SphingolipidsIBA 05/2022 - 01/2019
3	MucinsIBA 01/2022 - 01/2018
3	InterferonsIBA 03/2019 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 07/2007
2	LipidsIBA 05/2022 - 02/2015
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 10/2011
2	ChemokinesIBA 10/2020 - 11/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020 - 01/2020
2	SmokeIBA 10/2019 - 03/2014
2	CytokinesIBA 01/2019 - 11/2003
2	Protein Isoforms (Isoforms)IBA 05/2017 - 03/2006
2	16S Ribosomal RNAIBA 01/2017 - 01/2012
2	GlucocorticoidsIBA 01/2012 - 01/2010
2	HLA-DQ Antigens (HLA-DQ)IBA 01/2012 - 09/2010
2	Interleukin-33IBA 01/2012 - 09/2010
2	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 02/2010 - 11/2003
1	SphingomyelinsIBA 05/2022
1	Mucin 5ACIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	LigandsIBA 05/2021
1	Poly I-CIBA 05/2021
1	Toll-Like Receptor 3IBA 05/2021
1	Double-Stranded RNA (RNA, Double Stranded)IBA 05/2021
1	Aurora KinasesIBA 01/2021
1	Volatile Fatty AcidsIBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	ValeratesIBA 01/2020
1	Adenosine Diphosphate (ADP)IBA 11/2019
1	Troleandomycin (TAO)FDA Link 10/2019
1	thermozymocidin (myriocin)IBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Serine C-PalmitoyltransferaseIBA 01/2019
1	Interferon Type IIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Antimicrobial PeptidesIBA 01/2018
1	clonidine-displacing substance (ClDS)IBA 01/2018
1	MetalsIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Lipocalin-2IBA 01/2018
1	25-hydroxyvitamin DIBA 01/2017
1	AllergensIBA 01/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	Receptor for Advanced Glycation End ProductsIBA 01/2016
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2016
1	Moxifloxacin (Avelox)FDA Link 10/2015
1	TabletsIBA 10/2015
1	Azithromycin (Zithromax)FDA LinkGeneric 10/2015
1	Doxycycline (Periostat)FDA LinkGeneric 10/2015
1	Glutamic Acid (Glutamate)FDA Link 02/2015
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2014
1	Plasma KallikreinIBA 02/2014
1	Urokinase Plasminogen Activator ReceptorsIBA 02/2014
1	AntigensIBA 04/2012
1	Janus KinasesIBA 04/2012

Therapy/Procedure

8	Therapeutics 01/2021 - 11/2003
1	Molecular Targeted Therapy 10/2021
1	Immunotherapy 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2015